Clements P J, Sargan D R, Gould D J, Petersen-Jones S M
Department of Clinical Veterinary Medicine, University of Cambridge.
J Small Anim Pract. 1996 Apr;37(4):155-62. doi: 10.1111/j.1748-5827.1996.tb01950.x.
Canine generalised progressive retinal atrophy (gPRA) is a large and ever-increasing collection of naturally occurring, heterogeneous, progressive disorders. Most are inherited in an autosomal recessive manner and new, breed-specific forms continue to be described. The gPRAs cause photoreceptor cell death and subsequent retinal degeneration, culminating in blindness. In humans, similar inherited retinal dystrophies are recognised as retinitis pigmentosa and macular dystrophy. Molecular biological studies have revealed disease-causing mutations in several genes in humans and also in mice with retinal dystrophies. Recently, molecular genetic techniques have identified the cause of one form of gPRA in Irish setters while important candidate genes have been investigated in other breeds. Identification of mutations responsible for different forms of gPRA allows carrier and predegenerate animals to be detected using DNA-based tests. Such genetic tests will greatly facilitate the eradication of these diseases in different breeds.
犬类全身性进行性视网膜萎缩(gPRA)是一大类且数量不断增加的自然发生的、异质性的、进行性疾病。大多数以常染色体隐性方式遗传,并且新的、特定品种的形式不断被描述。gPRA导致光感受器细胞死亡及随后的视网膜变性,最终导致失明。在人类中,类似的遗传性视网膜营养不良被认为是色素性视网膜炎和黄斑营养不良。分子生物学研究已经揭示了人类以及患有视网膜营养不良的小鼠中几个基因的致病突变。最近,分子遗传学技术已经确定了爱尔兰雪达犬中一种gPRA的病因,同时在其他品种中也对重要的候选基因进行了研究。鉴定出导致不同形式gPRA的突变,使得可以使用基于DNA的检测方法来检测携带者和处于疾病前期的动物。此类基因检测将极大地促进在不同品种中根除这些疾病。